Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 12 studies | 27% ± 16% | |
macrophage | 11 studies | 22% ± 8% | |
B cell | 9 studies | 24% ± 10% | |
conventional dendritic cell | 6 studies | 29% ± 21% | |
monocyte | 5 studies | 23% ± 9% | |
non-classical monocyte | 5 studies | 37% ± 22% | |
epithelial cell | 5 studies | 42% ± 19% | |
endothelial cell | 5 studies | 25% ± 8% | |
fibroblast | 5 studies | 22% ± 6% | |
natural killer cell | 4 studies | 27% ± 11% | |
naive B cell | 4 studies | 17% ± 1% | |
myeloid cell | 4 studies | 31% ± 13% | |
ciliated cell | 4 studies | 33% ± 8% | |
plasmacytoid dendritic cell | 4 studies | 30% ± 5% | |
pancreatic A cell | 3 studies | 32% ± 8% | |
CD16-positive, CD56-dim natural killer cell, human | 3 studies | 26% ± 4% | |
CD4-positive, alpha-beta T cell | 3 studies | 29% ± 9% | |
CD8-positive, alpha-beta T cell | 3 studies | 32% ± 14% | |
hematopoietic precursor cell | 3 studies | 34% ± 11% | |
memory B cell | 3 studies | 17% ± 2% | |
pericyte | 3 studies | 21% ± 5% | |
plasma cell | 3 studies | 31% ± 15% | |
basal cell | 3 studies | 33% ± 8% | |
neuron | 3 studies | 26% ± 13% | |
dendritic cell | 3 studies | 47% ± 28% | |
goblet cell | 3 studies | 27% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5064.12 | 1445 / 1445 | 100% | 57.13 | 183 / 183 |
ovary | 100% | 6020.24 | 180 / 180 | 100% | 53.60 | 430 / 430 |
pancreas | 100% | 3466.44 | 328 / 328 | 100% | 50.28 | 178 / 178 |
skin | 100% | 6690.14 | 1809 / 1809 | 100% | 58.20 | 472 / 472 |
thymus | 100% | 5254.46 | 653 / 653 | 100% | 58.31 | 605 / 605 |
brain | 100% | 4029.18 | 2638 / 2642 | 100% | 71.31 | 705 / 705 |
uterus | 100% | 6224.84 | 170 / 170 | 100% | 56.35 | 458 / 459 |
stomach | 100% | 4452.07 | 359 / 359 | 100% | 50.11 | 285 / 286 |
intestine | 100% | 5440.44 | 966 / 966 | 100% | 53.00 | 525 / 527 |
adrenal gland | 100% | 5481.53 | 258 / 258 | 100% | 41.16 | 229 / 230 |
kidney | 100% | 4582.43 | 89 / 89 | 99% | 51.46 | 896 / 901 |
prostate | 100% | 5158.02 | 245 / 245 | 99% | 47.10 | 499 / 502 |
lung | 100% | 5743.26 | 578 / 578 | 99% | 46.47 | 1145 / 1155 |
breast | 100% | 5670.65 | 459 / 459 | 99% | 46.14 | 1107 / 1118 |
bladder | 100% | 5457.90 | 21 / 21 | 99% | 54.52 | 498 / 504 |
liver | 100% | 2157.96 | 226 / 226 | 95% | 23.85 | 387 / 406 |
adipose | 100% | 5845.51 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 66.53 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 78.52 | 29 / 29 |
muscle | 100% | 13651.27 | 803 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 7275.16 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 6894.08 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 53.50 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 31.12 | 1 / 1 |
blood vessel | 100% | 4740.57 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 4449.68 | 855 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007498 | Biological process | mesoderm development |
GO_0007276 | Biological process | gamete generation |
GO_0006470 | Biological process | protein dephosphorylation |
GO_0007077 | Biological process | mitotic nuclear membrane disassembly |
GO_0090263 | Biological process | positive regulation of canonical Wnt signaling pathway |
GO_0006998 | Biological process | nuclear envelope organization |
GO_0034504 | Biological process | protein localization to nucleus |
GO_0010867 | Biological process | positive regulation of triglyceride biosynthetic process |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0005737 | Cellular component | cytoplasm |
GO_0071595 | Cellular component | Nem1-Spo7 phosphatase complex |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005811 | Cellular component | lipid droplet |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0017018 | Molecular function | myosin phosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0004722 | Molecular function | protein serine/threonine phosphatase activity |
Gene name | CTDNEP1 |
Protein name | CTD nuclear envelope phosphatase 1 (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard) protein-serine/threonine phosphatase (EC 3.1.3.16) CTD nuclear envelope phosphatase 1 |
Synonyms | DULLARD |
Description | FUNCTION: Serine/threonine protein phosphatase forming with CNEP1R1 an active phosphatase complex that dephosphorylates and may activate LPIN1 and LPIN2. LPIN1 and LPIN2 are phosphatidate phosphatases that catalyze the conversion of phosphatidic acid to diacylglycerol and control the metabolism of fatty acids at different levels. May indirectly modulate the lipid composition of nuclear and/or endoplasmic reticulum membranes and be required for proper nuclear membrane morphology and/or dynamics. May also indirectly regulate the production of lipid droplets and triacylglycerol. May antagonize BMP signaling. . |
Accessions | I3L2R5 ENST00000574322.6 ENST00000574205.5 ENST00000573600.5 O95476 ENST00000572043.5 ENST00000570828.5 ENST00000318988.10 I3L1D9 I3L4B2 ENST00000570380.5 ENST00000575783.5 I3L0X6 ENST00000571409.1 ENST00000576613.5 I3L3K5 I3L4W0 |